Analyst Downgrades for October 19th

Analyst Downgrades for 10/19/2009... Accenture (NYSE:ACN) downgraded to Neutral from Buy, $39 target, at UBS... Amdocs (NYSE:DOX) downgraded to Neutral from Buy, $27 target, at UBS... CareFusion (NYSE:CFN) initiated as Market Perform at Leerink Swann; also initiated as Neutral at JPMorgan... Cellcom Isreal (NYSE:CEL) downgraded to Hold at Deutsche Bank... Fannie Mae (NYSE:FNM) downgraded to Underperform from Market Perform, $0 target, at Keefe Bruyette... First Solar (NASDAQ:FSLR) downgraded to Neutral from Outperform at Macquarie... Freddie Mac (NYSE:FRE) downgraded to Underperform from Market Perform, $0 target, at Keefe Bruyette... Par Pharmaceutical (NYSE:PRX) downgraded to Neutral from Buy at BofA/Merrill... Sanderson Farms (NASDAQ:SAFM) downgraded to Hold at KeyBanc... SL Green Realty (NYSE:SLG) downgraded to Neutral from Buy, $45 target, at BofA/Merrill... Southwest (NYSE:LUV) downgraded to Underweight from Neutral at JP Morgan.... Suntech (NYSE:STP) downgraded to Underperform from Neutral at Macquarie... Tellabs (NASDAQ:TLAB) downgraded to Neutral from Buy, $7.50 target, at UBS...

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Related terms: fannie mae, freddie mac, market, nasdaq, nyse, pharmaceuticals, securities